The comparison changed analgesia while retaining midazolam in every group.
The single-center trial randomized 105 ventilated surgical-ICU patients to remifentanil plus midazolam, fentanyl plus midazolam, or midazolam alone. Both analgesic groups required less daily midazolam. The remifentanil group had a lower reported delirium occurrence than control.
Because all groups received midazolam, the trial cannot establish the effect of removing benzodiazepines or choosing propofol or dexmedetomidine instead. Its small surgical-ICU population restricts transfer to other critical-care settings. Reduced dose and reduced delirium do not alone establish the precise mechanism linking them.
For testimony, describe the intervention as an analgesic-based regimen rather than a direct benzodiazepine class trial. Consider pain relief, sedation targets and total exposure together. The study supports attention to the treatment strategy while leaving several causal pathways unresolved.
Source: Publication PMC5598969, read from the supplied PDF. Applications to expert analysis are interpretation.
Related reading: Multimedia Bronchoscopy Information Reduced Midazolam Requirements in a Randomized Study.